Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers.
Affiliation
Department of Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, CanadaIssue Date
2016-01-13
Metadata
Show full item recordAbstract
To investigate the predictive and prognostic values of DNA repair genes excision repair cross-complementation group 1 (ERCC1) and X-ray repair cross-complementing group 1 (XRCC1) in tumour samples from patients with a diagnosis of biliary tract cancer (BTC).Citation
Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers. 2016: J Clin PatholJournal
Journal of Clinical PathologyDOI
10.1136/jclinpath-2015-203397PubMed ID
26763622Type
ArticleLanguage
enISSN
1472-4146ae974a485f413a2113503eed53cd6c53
10.1136/jclinpath-2015-203397
Scopus Count
Collections
Related articles
- Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy.
- Authors: Fisher SB, Fisher KE, Patel SH, Lim MG, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Farris AB 3rd, Maithel SK
- Issue date: 2013 Jan 15
- ERCC1 in advanced biliary tract cancer patients treated with chemotherapy: prognostic and predictive roles.
- Authors: da Costa Miranda V, Braghiroli MI, Faria LD, Siqueira SA, Sabbaga J, Hoff PM, Riechelmann RP
- Issue date: 2014 Mar
- Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection.
- Authors: Maithel SK, Coban I, Kneuertz PJ, Kooby DA, El-Rayes BF, Kauh JS, Sarmiento J, Staley CA 3rd, Volkan Adsay N
- Issue date: 2011 Sep
- Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.
- Authors: Postlewait LM, Ethun CG, Kooby DA, Sarmiento JM, Chen Z, Staley CA 3rd, Brutcher E, Adsay V, El-Rayes B, Maithel SK
- Issue date: 2016 Sep
- Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
- Authors: Tan ES, Cao B, Kim J, Al-Toubah TE, Mehta R, Centeno BA, Kim RD
- Issue date: 2021 Apr 15